Literature DB >> 19707862

Heterozygous carriers for Wilson's disease--magnetic spectroscopy changes in the brain.

Beata Tarnacka1, Wojciech Szeszkowski, Janine Buettner, Marek Gołebiowski, Grazyna Gromadzka, Anna Członkowska.   

Abstract

Wilson's disease (WD) is an autosomal recessive disorder and the WD heterozygote carriers (Hzc) should not exhibit symptoms of the disease. The aim of this study was to assess 12 WD Hzc by brain Proton MR Spectroscopy. In three cases, the levels of caeruloplasmin, and in one case, serum copper, were below our normal range. In two Hzc the aspartate and alanine aminotransferase levels in the blood were slightly increased, however, no ultrasonographic liver changes were detected. The brain metabolite analysis showed a statistically significant higher mean ratio of Glx/Cr and Lip/Cr in MRS in Hzc in both the pallidum and thalami compared to control subjects. Our results suggest that WD Hzc may accumulate free copper in the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19707862     DOI: 10.1007/s11011-009-9145-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  11 in total

1.  Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease.

Authors:  G Gromadzka; H H-J Schmidt; J Genschel; B Bochow; M Rodo; B Tarnacka; T Litwin; G Chabik; A Członkowska
Journal:  Clin Genet       Date:  2005-12       Impact factor: 4.438

2.  Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease.

Authors:  Slavka Vrabelova; Ondrej Letocha; Marek Borsky; Libor Kozak
Journal:  Mol Genet Metab       Date:  2005-06-20       Impact factor: 4.797

3.  Glucose and synaptosomal glutamate metabolism: studies with [15N]glutamate.

Authors:  M Erecińska; M M Zaleska; I Nissim; D Nelson; F Dagani; M Yudkoff
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

Review 4.  Spatial localization in NMR spectroscopy in vivo.

Authors:  P A Bottomley
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  Is Parkinson's disease the heterozygote form of Wilson's disease: PD = 1/2 WD?

Authors:  S Johnson
Journal:  Med Hypotheses       Date:  2001-02       Impact factor: 1.538

6.  Late-onset Wilson's disease.

Authors:  Peter Ferenci; Anna Członkowska; Uta Merle; Szalay Ferenc; Grazyna Gromadzka; Cihan Yurdaydin; Wolfgang Vogel; Radan Bruha; Hartmut T Schmidt; Wolfgang Stremmel
Journal:  Gastroenterology       Date:  2007-02-25       Impact factor: 22.682

7.  Dietary copper and high saturated and trans fat intakes associated with cognitive decline.

Authors:  Martha Clare Morris; Denis A Evans; Christine C Tangney; Julia L Bienias; Julie A Schneider; Robert S Wilson; Paul A Scherr
Journal:  Arch Neurol       Date:  2006-08

8.  Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers.

Authors:  Daphne M Y Cheah; Yolanda J Deal; Paul F A Wright; Nicole E Buck; Chung Wo Chow; Julian F B Mercer; Katrina J Allen
Journal:  Biometals       Date:  2006-11-29       Impact factor: 2.949

Review 9.  Clinical consequences of heterozygosity for autosomal-recessive diseases.

Authors:  F Vogel
Journal:  Clin Genet       Date:  1984-05       Impact factor: 4.438

10.  Wilson's disease: MRI demonstration of cavitations in basal ganglia and thalami.

Authors:  R N Sener
Journal:  Pediatr Radiol       Date:  1993
View more
  5 in total

1.  Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism.

Authors:  G Gromadzka; G Chabik; T Mendel; A Wierzchowska; M Rudnicka; A Czlonkowska
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease.

Authors:  Oktay Algin; Ozlem Taskapilioglu; Bahattin Hakyemez; Gokhan Ocakoglu; Sukran Yurtogullari; Sevda Erer; Mufit Parlak
Journal:  Jpn J Radiol       Date:  2010-11-27       Impact factor: 2.374

3.  Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Authors:  Rakesh Jadav; Jitender Saini; Sanjib Sinha; Bhavanishankara Bagepally; S Rao; Arun B Taly
Journal:  Metab Brain Dis       Date:  2013-05-01       Impact factor: 3.584

4.  Transcranial sonography changes in heterozygotic carriers of the ATP7B gene.

Authors:  Marta Skowronska; Tomasz Litwin; Iwona Kurkowska-Jastrzębska; Anna Członkowska
Journal:  Neurol Sci       Date:  2020-04-09       Impact factor: 3.307

5.  A novel heterozygous carrier of ATP7B mutation with muscle weakness and tremor: A Chinese Case Report.

Authors:  Zhengxiang Zhang; Jiayi Liu; Wenjing Zheng; Qun Hou; Liping Zhang
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-12-01       Impact factor: 2.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.